International classification of diseases coding changes lead to profound declines in reported idiopathic pulmonary arterial hypertension mortality and hospitalizations: Implications for database studies

Chest

Volumn 139, Issue 3, 2011, Pages 497-504

  Link, Jeffrey ^a   Glazer, Craig ^a   Torres, Fernando ^a   Chin, Kelly ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ESSENTIAL HYPERTENSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MORTALITY; NEGRO; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REFERENCE DATABASE; SENESCENCE;

EID: 79952209990     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-0837     Document Type: Article

References (19)

1. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France:results from a national registry. Am J Respir Crit Care Med. 2006;173(9):1023-1030.
2. Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J. 2007;30(6):1103-1110.
3. Centers for Disease Control and Prevention. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). http://www.cdc.gov/nchs/icd/icd9cm.htm. Accessed February 17, 2010.
4. Rubin LJ. Primary pulmonary hypertension. Chest. 1993;104(1): 236-250. (Pubitemid 23204564)
5. Thomas AJ. Chronic pulmonary heart disease. Br Heart J. 1972;34(7):653-657.
6. Chronic cor pulmonale. Report of an expert committee. Circulation. 1963;27(4):594-615.
7. Lilienfeld DE, Rubin LJ. Mortality from primary pulmonary hypertension in the United States, 1979-1996. Chest. 2000; 117(3):796-800.
8. Hyduk A, Croft JB, Ayala C, Zheng K, Zheng ZJ, Mensah GA. Pulmonary hypertension surveillance - United States, 1980-2002. MMWR Surveill Summ. 2005;54(5):1-28.
9. McLaughlin VV, Archer SL, Badesch DB, et al;ACCF/AHA. ACCF/AHA 2009 expert consensus document on pulmonary hypertension:a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association:developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009;119(16):2250-2294.
10. Movahed MR, Hashemzadeh M, Jamal MM. The prevalence of pulmonary embolism and pulmonary hypertension in patients with type II diabetes mellitus. Chest. 2005;128(5): 3568-3571. (Pubitemid 41698694)
11. Davis KK, Lilienfeld DE, Doyle RL. Increased mortality in African Americans with idiopathic pulmonary arterial hypertension. J Natl Med Assoc. 2008;100(1):69-72. (Pubitemid 351224259)
12. National Center for Health Statistics Coordination and Maintenance Committee. ICD-9-CM Coordination and Maintenance Committee Meeting, May 13, 2009, Summary. http://www.cdc.gov/nchs/data/icd9/icdm599.pdf. Accessed November 28, 2008.
13. Peacock AJ, Murphy NF, McMurray JJV, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007;30(1):104-109. (Pubitemid 47074013)
14. Carrington M, Murphy NF, Strange G, Peacock A, McMurray JJ, Stewart S. Prognostic impact of pulmonary arterial hypertension: a population-based analysis. Int J Cardiol. 2008; 124(2):183-187. (Pubitemid 351173359)
15. Shapiro BP, McGoon MD, Redfield MM. Unexplained pulmonary hypertension in elderly patients. Chest. 2007;131(1):94-100. (Pubitemid 46122979)
16. Rich S. How do we explain unexplained pulmonary hypertension in the elderly? Chest. 2007;131(1):5-6.
17. Robbins IM, Newman JH, Johnson RF, et al. Association of the metabolic syndrome with pulmonary venous hypertension. Chest. 2009;136(1):31-36.
18. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54(1 suppl):S43-S54.
19. Rothman RB. The age-adjusted mortality rate from primary pulmonary hypertension, in age range 20 to 54 years, did not increase during the years of peak "phen/fen"use. Chest. 2000;118(5):1516-1517.